Your session is about to expire
← Back to Search
mHealth Messaging for New Mothers (SMARTER Trial)
N/A
Recruiting
Led By Michael J Corwin, MD
Research Sponsored by Boston University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Must speak English or Spanish
Timeline
Screening 3 weeks
Treatment Varies
Follow Up between 2 and 6 months
Awards & highlights
No Placebo-Only Group
Summary
This trial looks at whether sending text messages about safe sleep and breastfeeding can help new mothers follow AAP recommendations.
Who is the study for?
This trial is for pregnant women in the U.S. under 34 weeks gestation, planning to live with their infant post-birth, and who are clients at a participating WIC center. They must speak English or Spanish and have texting capabilities on their mobile phone. It's not for minors or those with prenatal diagnoses affecting breastfeeding/sleep positioning.
What is being tested?
The study tests if mHealth messages about safe sleep and breastfeeding sent directly to mothers' phones can increase adherence to safe sleep practices and improve breastfeeding rates. It involves sending educational text messages both before and after birth.
What are the potential side effects?
Since this trial involves educational messaging via mobile health technologies, there are no direct medical side effects associated with the interventions being tested.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I speak English or Spanish.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ between 2 and 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~between 2 and 6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Breast milk feeding in the previous two weeks
Pacifier use in the previous two weeks
Soft bedding use in the previous two weeks
+2 moreSecondary study objectives
Age in weeks when Infant stopped supine sleep position
Age in weeks when infant breast milk feedings change
Age in weeks when infant starts to use a pacifier
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
4Treatment groups
Experimental Treatment
Group I: Prenatal SS/Postnatal SSExperimental Treatment2 Interventions
Prenatal Safe Sleep/Postnatal Safe Sleep Mobile Health Messages
Group II: Prenatal SS/Postnatal BFExperimental Treatment2 Interventions
Prenatal Safe Sleep/Postnatal Breastfeeding Mobile Health Messages
Group III: Prenatal BF/Postnatal SSExperimental Treatment2 Interventions
Prenatal Breastfeeding/Postnatal Safe Sleep Mobile Health Messages
Group IV: Prenatal BF/Postnatal BFExperimental Treatment2 Interventions
Prenatal Breastfeeding/Postnatal Breastfeeding Mobile Health Messages
Find a Location
Who is running the clinical trial?
Washington University School of MedicineOTHER
1,987 Previous Clinical Trials
2,289,079 Total Patients Enrolled
Boston UniversityLead Sponsor
470 Previous Clinical Trials
9,985,248 Total Patients Enrolled
University of VirginiaOTHER
781 Previous Clinical Trials
1,313,170 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am pregnant and less than 34 weeks along.I am considered a minor by my state's laws.I speak English or Spanish.
Research Study Groups:
This trial has the following groups:- Group 1: Prenatal SS/Postnatal SS
- Group 2: Prenatal BF/Postnatal SS
- Group 3: Prenatal BF/Postnatal BF
- Group 4: Prenatal SS/Postnatal BF
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger